Chris Nolet
Director · ArriVent BioPharma, Inc.
Individual
- 2025
- Jun 23, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Chris Nolet files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- HILLHOUSE INVESTMENT MANAGEMENT, LTD. - $12.98M in AVBP purchases and sales in the last 12 months
- Patrick J. Crutcher - JSPR
- Matthew E. Ros - JSPR
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Chris Nolet?
Chris Nolet is a corporate insider, tracked as Director of ArriVent BioPharma, Inc. (AVBP). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Chris Nolet last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 2 filings going back to 2025.
